Skip to content

Comparison between clomiphene citrate plus hMG or hMG alone, combined with flexible multi dose GnRH antagonist for patients with poor prognosis in IVF-ET programs

Comparison between clomiphene citrate plus hMG or hMG alone, combined with flexible multi dose GnRH antagonist for patients with poor prognosis in IVF-ET programs - Clomiphene citrate plus HMG or hMG alone combined with flexible multi dose GnRH antagonist for patients with poor prognosis in IVF-ET programs

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000008760
Enrollment
110
Registered
2012-08-24
Start date
2011-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertile patient and poor responder in controlled ovarian hyperstimulation

Interventions

hMG-GnRH antagonist: start HMG(FSH:LH 1:1) from day3 until the day of hCG administration. Concomitant treatment with Ganirelix 0.25mg s.c. in multiple, flexible method when leading follicle reaches 14

Sponsors

Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) require IVF-ET for infertility treatment 2) less than four-times-history of controlled ovarian hyper stimulation with GnRH antagonist 3) Exhibit ovarian dysfunction by the findings such as basal FSH above 10 mIU/ml, antral follicle count below 7, and oocyte retrieval below 5 in the previous cycle.

Exclusion criteria

Exclusion criteria: 1) above 46 years of age 2) not allowed to be pregnant due to other medical complications 3) scheduled to undergo freezing of all embryos due to gynecological conditions such as myomas and adenomyosis.

Design outcomes

Primary

MeasureTime frame
Evaluate the clinical pregnancy rate per ovarian stimulation, oocyte retrieval, and embryo transfer.

Countries

Japan

Contacts

Public ContactHajime Oishi

The University of Tokyo, Faculty of Medicine Department of Obstetrics and Gynecology

hooishi-tky@umin.ac.jp03-3815-5411(ext.33407)

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026